Stevens Capital Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-76,820	Closed	-$10.1M	–	835
2019 Q2	$10.1M	Buy	76,820 +48,802	+174%	+$6.29M	0.45%	51
2019 Q1	$3.79M	Sell	28,018 -73,835	-72%	-$9.18M	0.16%	172
2018 Q4	$9.92M	Buy	+101,853	New	+$12M	0.51%	37
2018 Q1	–	Sell	-12,660	Closed	-$1.51M	–	1062
2017 Q4	$1.51M	Sell	12,660 -1,321	-9%	-$161K	0.06%	352
2017 Q3	$1.96M	Sell	13,981 -53,407	-79%	-$7.26M	0.07%	314
2017 Q2	$8.2M	Buy	+67,388	New	+$7.84M	0.31%	103
2017 Q1	–	Sell	-3,884	Closed	-$475K	–	1178
2016 Q4	$475K	Sell	3,884 -25,287	-87%	-$3.09M	0.02%	593
2016 Q3	$3.58M	Sell	29,171 -21,621	-43%	-$2.78M	0.15%	180
2016 Q2	$5.93M	Buy	+50,792	New	+$7.21M	0.24%	122
2015 Q2	–	Sell	-88,222	Closed	-$15.3M	–	1312
2015 Q1	$15.3M	Buy	88,222 +59,232	+204%	+$10.7M	0.54%	47
2014 Q4	$5.36M	Sell	28,990 -7,294	-20%	-$1.35M	0.18%	149
2014 Q3	$6.02M	Sell	36,284 -155,151	-81%	-$25.5M	0.18%	154
2014 Q2	$29.9M	Buy	191,435 +183,913	+2,445%	+$29M	0.8%	15
2014 Q1	$1.14M	Buy	+7,522	New	+$1.2M	0.03%	455